Skip to content
    O

    Oriza

    Oriza is a Series A to Series D stage investment firm. It has made 22 investments. 51% of their portfolio is in Biotech & Life Sciences. They made 1 investment in the last 12 months. Average disclosed round size is $64.5M (across 21 rounds with reported amounts).

    Find people at Oriza on Goldilocks AI

    Portfolio

    22

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    1

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    35 investments
    CompanyRoundAmountDate
    AAccroSeries C$50MMay 2026
    Eluminex Biosciences logoEluminex BiosciencesSeries B—Feb 2023
    Angitia Biopharmaceuticals logoAngitia BiopharmaceuticalsSeries B$40MJan 2023
    TuringQ logoTuringQSeries A—Jan 2023
    AAngitia BioSeries B$40MJan 2023
    TuringQ logoTuringQUnknown—Feb 2022
    TuringQ logoTuringQUnknown—Jan 2022
    Tavotek logoTavotekSeries B$35MNov 2021
    DDuality BiologicsSeries B$90MMay 2021
    Elpiscience logoElpiscienceSeries C$105MMay 2021
    YYikon GenomicsSeries D$38.7MJan 2021
    JW Therapeutics logoJW TherapeuticsSeries B$100MJun 2020
    PegBio logoPegBioIpo—Jan 2020
    Eluminex Biosciences logoEluminex BiosciencesSeries A$50MJan 2020
    Biocytogen logoBiocytogenSeries D$79MJan 2020
    Elpiscience logoElpiscienceSeries B$100MDec 2019
    Elpiscience logoElpiscienceSeries A$20MDec 2018
    Ascentage Pharma logoAscentage PharmaSeries C$150MJul 2018
    UCloud logoUCloudSeries D$139MMar 2017
    Ascentage Pharma logoAscentage PharmaUnknown—Jan 2017
    UCloud logoUCloudSeries D$139MJan 2017
    YYikon GenomicsSeries B$21MJan 2016
    Ascentage Pharma logoAscentage PharmaSeries A$15.5MAug 2015
    Ascentage Pharma logoAscentage PharmaSeries A$15.5MJan 2015
    PegBio logoPegBioGrowth—Jan 2014
    Page 1 of 2

    Top Co-Investors

    LAV9 shared
    Legend Capital6 shared
    Hillhouse Investment4 shared
    3E Bioventures Capital3 shared
    Cormorant Asset Management3 shared
    Dyee Capital3 shared
    CDH Investments3 shared
    OrbiMed3 shared
    Oriza Seed Venture Capital3 shared
    Northern Light Venture Capital2 shared
    LYZZ Capital2 shared
    WuXi Healthcare Ventures2 shared
    Parkway Venture Capital2 shared
    China Life Insurance (Group) Company2 shared
    YuanBio Venture Capital2 shared
    Oriza Ventures2 shared
    Elikon Venture2 shared
    Morningside2 shared
    Scheme Capital2 shared
    Amber Group2 shared

    Last updated: 20 October 2026